COVID-19 herd immunity by immunisation: are children in the herd?

Author of this Comment discusses clinical observations relevant for formulating COVID-19 vaccines for deployment in children, from an immunological, public health and ethical perspective, and welcomes the start of efficacy trials in youths aged 12–18 years.

The Lancet Infectious Diseases